Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
Clinical trial NCT01878812 · COMPLETED
Trial details
- NCT number
- NCT01878812
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-11
- Primary completion
- 2013-08-05
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.